Abcuro Secures $200M Series C to Advance Ulviprubart for IBM
Key Highlights Abcuro raises $200M in Series C funding led by New Enterprise Associates (NEA) with participation from…
Browsing Tag
Foresite Capital
7 posts
Spear Bio Inc. Secures $45 Million Series A Financing
Key Highlights Spear Bio Inc. raises $45 million in Series A financing. Co-led by Foresite Capital and Bio-Techne…
Thyme Care Secures $95M to Transform Value-Based Cancer Care
Key Highlights $95M capital raise, including $55M in equity and $40M in debt financing. New investor Concord Health Partners joins…
Foresite Capital Promotes Drs. Hyung Chun and Cindy Xiong to Partner
Key Highlights Foresite Capital promotes Drs. Hyung Chun and Cindy Xiong to partner roles. Chun and Xiong to lead investments…
Foresite Capital Closes Sixth Fund with $900 Million in Commitments
Key Highlights Foresite Capital closes Fund VI with $900 million in commitments. Investments focus on precision therapeutics, life…
Avenzo Therapeutics Closes $150M Series A-1 Financing
Key Highlights Oversubscribed $150 million Series A-1 financing led by New Enterprise Associates, Deep Track Capital, Sofinnova Investments, and…
Odyssey Therapeutics Secures $101 Million in Series C Funding to Propel Immunomodulators and Oncology Medicines
Key Highlights Odyssey Therapeutics, Inc. completes a significant $101 million Series C financing round led by Ascenta Capital. The funding will…